Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)
- Conditions
- Atopic DermatitisAtopic Dermatitis EczemaEczema
- Registration Number
- NCT03823794
- Lead Sponsor
- Momentum Data
- Brief Summary
Atopic dermatitis (AD), commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becoming increasingly common in less developed countries. Exact estimates of how common eczema is, vary considerably and there has not been an in-depth analysis of the number of people with eczema in the UK. It is also unclear which groups of people are most affected and which treatment options are being used.
Most people with eczema are managed by their general practitioner (GP) with only a few people requiring specialist care. GP records therefore provide an excellent opportunity to explore how common eczema is and which treatments are being used currently.
- Detailed Description
Objective
The study aims to describe the health care resource utilisation of patients with active AD in terms of prescription use, primary care appointments, and specialist referrals.
Method This study will define AD cases using a previously validated algorithm for case identification use clinical codes form primary care in the UK (Read codes). The study will analyse a cohort of prevalent active AD cases over a one year period (2018). The annual use of topical and oral medications used for the treatment of AD, primary care appointments, and specialist referrals will be reported.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 148166
- All paediatric and adult patients registered with an Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) contributing GP practice during the study period (2008-2018) and with at least one year of follow-up.
- The presence of psoriasis, photodermatitis, or ichthyosis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prescription Rates for Atopic Dermatitis Related Treatments: Mild Topical Corticosteroids (TCS) Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for mild topical corticosteroids (atopic dermatitis related treatment)
Prescription Rates for Atopic Dermatitis Related Treatments: Topical Antimicrobials Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for topical antimicrobials.
Prescription Rates for Atopic Dermatitis Related Treatments: Emollients and Soap Substitutes Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for emollients and soap substitutes.
Prescription Rates for Atopic Dermatitis Related Treatments: Moderate Topical Corticosteroids (TCS) Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for moderate topical corticosteroids (an atopic dermatitis related treatment)
Prescription Rates for Atopic Dermatitis Related Treatments: Potent Topical Corticosteroids (TCS) Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for potent topical corticosteroids (an atopic dermatitis related treatment)
Prescription Rates for Atopic Dermatitis Related Treatments: Very Potent Topical Corticosteroids (TCS) Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for very potent topical corticosteroid (an atopic dermatitis related treatment)
Prescription Rates for Atopic Dermatitis Related Treatments: Topical Calcineurin Inhibitors (TCI) Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for a topical Calcineurin Inhibitor (an atopic dermatitis related treatment)
Specialist Referrals Jan - Dec 2018 inclusive Specialist dermatology referral rate in 2018
Prescription Rates for Atopic Dermatitis Related Treatments: Antihistamin Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for antihistamin.
Prescription Rates for Atopic Dermatitis Related Treatments: Systemic Immuno-modulatory Therapy Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for Systemic immuno-modulatory therapy
Prescription Rates for Atopic Dermatitis Related Treatments: Oral Corticosteroids Jan - Dec 2018 inclusive Proportion of the arm/group receiving at least one prescription for oral corticosteroids
Primary Care Referrals Jan - Dec 2018 inclusive Annual rate of primary care consultations in 2018
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Momentum Data Ltd
🇬🇧London, United Kingdom
Momentum Data Ltd🇬🇧London, United Kingdom